How this shows up in interviews

"Walk me through MEDDPICC." Do not recite. Take a real or realistic deal and narrate the letters as evidence: "The pain was documented on their risk register with a cost attached; the metrics were their QA lead's own model, not ours; the economic buyer was the COO, whom I met twice and who set a condition..." Land two premium points: that unknown is red rather than amber, and that you used it as a diagnostic rather than a stage gate. This alone will put you ahead of most experienced reps, who default to reciting the acronym.

"How do you know you have a real champion?" Answer behaviourally and give the three tests — power, personal win, and a costly action — then give the specific test you actually run: ask them to arrange access to the economic buyer, or to send your business case internally under their own name. Close with the distinction interviewers rarely hear articulated: "Every champion is a coach, not every coach is a champion, and a cheerleader is neither — the difference is what they've done, not how they feel."

"Which MEDDPICC letter do reps most often get wrong, and why?" Economic buyer, because a name is easy to type and "I've never met them" is the most embarrassing thing to say in a deal review. Explain the invisible failure mode — quietly redefining the economic buyer downwards to whoever you have actually met — and give the test: if they say yes, does the money move? Then add the runner-up, paper process, because it decides when rather than whether, so it wrecks forecasts rather than deals.

"Talk me through a deal you'd walk away from." Use the four-part disqualification form: evidence, judgement, reallocation, trigger. "Two deflected requests for economic-buyer access, criteria briefed by the incumbent, no quantified pain; I don't believe it's winnable this year; I'm moving the time to these accounts; I'll re-engage if their contract renewal or a risk-register entry changes the picture." The reallocation and the trigger are what make it sound like a decision rather than an excuse.

"How would you handle a deal that's forecast to close but hasn't started legal?" This is the Kestrel scenario and it is a character question. Say you would revise the date and communicate it immediately, in writing, with evidence; then run the paper process as a project with named owners in legal, security and procurement, realistic queue lengths rather than target ones, and workstreams in parallel. Finish on the principle: volunteering a slip early is survivable, being found out on the last day of the quarter is not.

"Your only contact won't introduce you to anyone else. What do you do?" Give the escalating moves — send an artefact that requires another function's routing, thread laterally to peers first, use an executive-to-executive introduction, trade a genuinely valuable workshop for attendance, and finally name the constraint honestly. Add the safety rule that shows experience: transparency without permission-seeking, because going around someone after being asked not to buys one meeting and costs you your only ally.

"How big is a typical buying group, and what does that mean for how you sell?" Cite the range honestly: Gartner's widely used figure is six to ten decision-makers, and its 2025 survey of 632 buyers described groups from five to sixteen across as many as four functions, with most buyer teams showing unhealthy internal conflict. Then draw the operational conclusion — you map by function, not title, and a large part of the job is helping the group agree with itself, because internal disagreement kills more deals than competitor preference.

"Isn't MEDDPICC just box-ticking?" Agree with the criticism, then out-argue it. Yes, in most organisations it degenerates into eight CRM fields completed the night before a forecast call, and a dropdown reading "budget approved" tells you nothing about how money moves. The difference is whether the letters generate questions you ask the customer or text you type for your manager. A good follow-up to ask them: "Who reads the MEDDPICC fields here, and what's the forcing rule on what can't be committed?"

---

Cheat sheet

The eight letters, one line each

Scoring rules

• Green = externally verifiable. Amber = asserted but untested. Red = unknown, or known and bad.
• Unknown is red, not amber. Amber is not partial credit for work you haven't done.
• Never average. Three gates: Identify pain, Economic buyer, Champion — red on any makes the deal red. Two multipliers: Paper process (moves the date), Competition (moves the outcome). Three execution letters: Metrics, Criteria, Decision process.
• Score against the stage. Paper process red is fine in discovery and a crisis in negotiation.
• Re-score on every stage change and every material event. Anything older than three weeks is decoration.

Champion

• Three tests: power (influence, not seniority) · personal win (what they get) · action (something costly, done).
• Champion acts · coach informs · cheerleader neither. Audit behaviour, not warmth.
• Build: name their personal win → make them look good cheaply → teach them to sell internally → escalate the asks.
• Arm them for eight minutes without you: one-page business case in their numbers, a three-sentence narrative, an objection sheet, citable proof, and the specific ask.
• Always have a successor. Watch for "we" becoming "they".

Multi-threading

• Gartner: six to ten decision-makers typically; 2025 survey found five to sixteen across up to four functions, 74% with unhealthy internal conflict.
• Map seven functions: economic · operational · technical · security/IG · clinical or quality · procurement/legal · users.
• Sequence: operational → users and technical → economic buyer around the third engagement (Gong: starting with an executive cost ~6% win rate; involving them around touch three added ~5%) → security, quality and procurement in parallel, early.
• Stuck single-threaded: route an artefact → thread laterally → executive-to-executive → trade an event → name the constraint.
• Transparency without permission-seeking. Never go around someone silently.

Deal review

• Answer on rung three: artefact or event, not assertion or hearsay.
• "If I called your champion tonight, what would they say the next step is?" — if your answer differs, there is no mutual plan.
• A precise red beats a confident amber.
• Disqualify in four parts: evidence → judgement → reallocation → trigger.

Misuse

• Diagnostic, not stage gate. Advancement comes from customer-verifiable events.
• Economic buyer is the most faked letter; redefining it downwards is the invisible version.
• "We have a champion" usually means "we have a cheerleader". Audit in writing.
• Overkill on transactional deals — one or two buyers, sub-month cycle, no committee: use a lighter filter.

---

References & further reading

• John McMahon, The Qualified Sales Leader: Proven Lessons from a Five Time CRO (2021) — the closest thing to a primary source. McMahon led the sales organisation at PTC where MEDDIC was created, and the book's treatment of champions, economic buyers and the three levels of pain (found, quantified, implicated) is the deepest in print. Read the champion and forecasting chapters twice.
• Andy Whyte, MEDDICC: The ultimate guide to staying one step ahead in the complex sale (Meddicc Ltd, 2020) — written with contributions from Dick Dunkel and Jack Napoli, the framework's creators, which makes it the canonical modern text. Strongest on why the methodology gets a bad name when juniors treat it as a form to complete on every call.
• MEDDICC Ltd's resource library (meddicc.com) — free articles, definitions and the Masters of MEDDICC interview series, including episodes with Dick Dunkel on how the framework was built at PTC. Useful for hearing the letters discussed as working language rather than as an acronym.
• Force Management (forcemanagement.com) and the Revenue Builders podcast — the sales-training organisation whose Command of the Message and MEDDICC programmes many enterprise employers actually run; John Kaplan and John McMahon interview enterprise sales leaders on the podcast. If a job advert names Command of the Message, this is what it means.
• Brent Adamson, Matthew Dixon, Pat Spenner and Nick Toman, The Challenger Customer (2015) — the research behind consensus-buying and the "Mobilizer" concept: why winning over individual stakeholders can make group decisions harder, and why buying groups so often agree to do nothing. The best complement to MEDDPICC's champion and multi-threading letters.
• Gartner's sales and B2B buying research (gartner.com/en/sales) — the source of the buying-group figures used in this module, including the May 2025 survey of 632 B2B buyers on buying-group size, functional spread and internal conflict. Cite the ranges, not a single number, and check for updates before an interview.
• Gong Labs (gong.io/resources/labs) — large-sample analyses of recorded sales activity, including the executive-engagement and multi-threading work cited here. Treat as directional evidence from one vendor's dataset rather than as universal law, and quote it that way in interviews.
• NHS England's Digital Technology Assessment Criteria (DTAC) and the clinical risk management standards DCB0129 and DCB0160 — the assurance artefacts that populate the Decision criteria and Paper process letters in UK health-tech deals. DCB0129 applies to you as the manufacturer; DCB0160 applies to the deploying organisation, and a fresh DCB0160 assessment is needed for every deployment. An updated DTAC form was introduced in February 2026 with a transition deadline of 6 April 2026 — verify the current version before quoting it.

---